Cowen Inc’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-56,517
Closed -$30K 644
2018
Q3
$30K Buy
56,517
+18,617
+49% +$9.98K ﹤0.01% 395
2018
Q2
$19 Buy
+37,900
New +$17.7K ﹤0.01% 458
2017
Q1
Sell
-142,624
Closed -$54K 375
2016
Q4
$54K Buy
+142,624
New +$48.3K ﹤0.01% 235
2016
Q3
Sell
-33,334
Closed -$8K 334
2016
Q2
$8K Buy
+33,334
New +$5.73K ﹤0.01% 201

Other funds holding GCVRZ

Cowen Inc's GCVRZ Position: Q4 2018 in Review

Cowen Inc sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2018, closing a stake of 56,517 shares — an estimated $30K sold.

Cowen Inc first reported a position in GCVRZ in Q2 2016 and held it in 4 quarters. The position peaked at $54K in Q4 2016. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2018.

  • Cowen Inc reported no remaining Sanofi Contingent Value Rights position as of Q4 2018 after selling out during the quarter.
  • Cowen Inc sold 56,517 Sanofi Contingent Value Rights shares in Q4 2018, an estimated $30K.
  • Cowen Inc first reported a position in Sanofi Contingent Value Rights in Q2 2016 and held it in 4 quarters.
  • Cowen Inc's Sanofi Contingent Value Rights position peaked at $54K in Q4 2016.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2018.

Based on Cowen Inc's 13F filing for Q4 2018, filed 14 Feb 2019.